CA1276929C - Cephalosporin antibacterial agents - Google Patents

Cephalosporin antibacterial agents

Info

Publication number
CA1276929C
CA1276929C CA000474260A CA474260A CA1276929C CA 1276929 C CA1276929 C CA 1276929C CA 000474260 A CA000474260 A CA 000474260A CA 474260 A CA474260 A CA 474260A CA 1276929 C CA1276929 C CA 1276929C
Authority
CA
Canada
Prior art keywords
amino
alkyl
cephem
thiadiazol
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000474260A
Other languages
English (en)
French (fr)
Inventor
Masahisa Oka
Haruhiro Yamashita
Jun Okumura
Takayuki Naito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to CA000615909A priority Critical patent/CA1340609C/en
Application granted granted Critical
Publication of CA1276929C publication Critical patent/CA1276929C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA000474260A 1984-04-09 1985-02-14 Cephalosporin antibacterial agents Expired - Lifetime CA1276929C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000615909A CA1340609C (en) 1984-04-09 1990-10-25 Cephalosporin derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09
US597,941 1984-04-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000615909A Division CA1340609C (en) 1984-04-09 1990-10-25 Cephalosporin derivatives

Publications (1)

Publication Number Publication Date
CA1276929C true CA1276929C (en) 1990-11-27

Family

ID=24393575

Family Applications (3)

Application Number Title Priority Date Filing Date
CA000474260A Expired - Lifetime CA1276929C (en) 1984-04-09 1985-02-14 Cephalosporin antibacterial agents
CA000616143A Expired - Fee Related CA1340638C (en) 1984-04-09 1991-08-12 Cephalosporin derivatives
CA000616144A Expired - Fee Related CA1340672C (en) 1984-04-09 1991-08-21 Cephalosporin derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA000616143A Expired - Fee Related CA1340638C (en) 1984-04-09 1991-08-12 Cephalosporin derivatives
CA000616144A Expired - Fee Related CA1340672C (en) 1984-04-09 1991-08-21 Cephalosporin derivatives

Country Status (31)

Country Link
JP (4) JPS615084A (el)
KR (1) KR870002166B1 (el)
AR (1) AR244694A1 (el)
AT (1) AT388735B (el)
AU (2) AU580990B2 (el)
BE (1) BE902148A (el)
CA (3) CA1276929C (el)
CH (1) CH669197A5 (el)
DD (3) DD249024A5 (el)
DE (1) DE3512225A1 (el)
DK (1) DK155985A (el)
ES (4) ES8607318A1 (el)
FI (1) FI84830C (el)
FR (1) FR2563832B1 (el)
GB (3) GB2157293B (el)
GR (1) GR850883B (el)
HU (2) HU204277B (el)
IE (2) IE58408B1 (el)
IL (1) IL74826A (el)
IT (1) IT1190353B (el)
LU (1) LU85840A1 (el)
MY (1) MY101940A (el)
NL (1) NL192925C (el)
NZ (1) NZ211659A (el)
OA (1) OA07985A (el)
PT (1) PT80246B (el)
RU (1) RU2056425C1 (el)
SE (4) SE466205B (el)
SU (4) SU1436882A3 (el)
YU (2) YU46151B (el)
ZA (1) ZA852236B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
ATE114657T1 (de) * 1985-12-26 1994-12-15 Eisai Co Ltd Cephalosporin-verbindungen.
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 3−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
CA1339738C (en) * 1988-03-16 1998-03-17 Takashi Kamiya Process for the preparation of cephem derivatives and entermediates therefor
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
KR100248851B1 (ko) * 1994-08-16 2000-04-01 이치로 키타사토 신규 세펨 유도체
WO1999067255A1 (en) 1998-06-22 1999-12-29 F. Hoffmann-La Roche Ag Propenyl cephalosporin derivatives
WO2005026176A1 (ja) 2003-09-09 2005-03-24 Nippon Chemical Industrial Co.,Ltd. 3−クロロメチル-3-セフェム誘導体の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (el) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (el) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
ES8706694A1 (es) 1987-07-01
GR850883B (el) 1985-11-25
NZ211659A (en) 1988-11-29
RU2056425C1 (ru) 1996-03-20
IL74826A (en) 1990-01-18
SE8501680D0 (sv) 1985-04-03
JPS61143387A (ja) 1986-07-01
GB2157293B (en) 1988-10-05
AU610278B2 (en) 1991-05-16
JPS61143391A (ja) 1986-07-01
IE58408B1 (en) 1993-09-22
JPS615084A (ja) 1986-01-10
JPH0351716B2 (el) 1991-08-07
ES8706155A1 (es) 1987-06-01
FI84830C (fi) 1992-01-27
AT388735B (de) 1989-08-25
NL192925C (nl) 1998-05-07
JPH0262557B2 (el) 1990-12-26
JPH0357106B2 (el) 1991-08-30
AR244694A1 (es) 1993-11-30
KR850007424A (ko) 1985-12-04
SE8901226D0 (sv) 1989-04-06
SE466205B (sv) 1992-01-13
AU4086285A (en) 1985-10-17
YU60085A (en) 1987-12-31
NL192925B (nl) 1998-01-05
ES551550A0 (es) 1987-06-01
ES551551A0 (es) 1987-07-01
CH669197A5 (de) 1989-02-28
CA1340638C (en) 1999-07-06
ES8607318A1 (es) 1986-06-16
GB2194789A (en) 1988-03-16
SE8901224L (sv) 1989-04-06
IL74826A0 (en) 1985-07-31
IT8520267A0 (it) 1985-04-05
OA07985A (fr) 1987-01-31
GB2194790A (en) 1988-03-16
SE8901225L (sv) 1989-04-06
FI84830B (fi) 1991-10-15
GB2157293A (en) 1985-10-23
SE8901224D0 (sv) 1989-04-06
HUT37622A (en) 1986-01-23
ATA103985A (de) 1989-01-15
HU204277B (en) 1991-12-30
IE58403B1 (en) 1993-09-22
GB2194790B (en) 1988-10-05
ES8800949A1 (es) 1987-12-01
DD249024A5 (de) 1987-08-26
DD236735A5 (de) 1986-06-18
SE8901226L (sv) 1989-04-06
YU118987A (en) 1988-10-31
FR2563832A1 (fr) 1985-11-08
MY101940A (en) 1992-02-15
GB8508846D0 (en) 1985-05-09
DK155985D0 (da) 1985-04-03
JPS61143390A (ja) 1986-07-01
BE902148A (fr) 1985-10-09
SE470259B (sv) 1993-12-20
HU193750B (en) 1987-11-30
FI851379L (fi) 1985-10-10
AU580990B2 (en) 1989-02-09
NL8501002A (nl) 1985-11-01
ES557060A0 (es) 1987-12-01
GB8721347D0 (en) 1987-10-14
SU1375140A3 (ru) 1988-02-15
GB8721346D0 (en) 1987-10-14
DE3512225C2 (el) 1990-02-22
LU85840A1 (fr) 1985-12-16
KR870002166B1 (ko) 1987-12-14
YU46213B (sh) 1993-05-28
GB2194789B (en) 1988-10-12
ZA852236B (en) 1985-11-27
DK155985A (da) 1985-10-10
SE470260B (sv) 1993-12-20
SU1367858A3 (ru) 1988-01-15
FI851379A0 (fi) 1985-04-04
PT80246B (pt) 1987-10-20
FR2563832B1 (fr) 1989-08-18
YU46151B (sh) 1993-05-28
IE850866L (en) 1985-10-09
SE8501680L (sv) 1985-10-10
AU2504188A (en) 1989-03-02
SU1436882A3 (ru) 1988-11-07
IT1190353B (it) 1988-02-16
DD251752A5 (de) 1987-11-25
SE505256C2 (sv) 1997-07-21
JPH0350754B2 (el) 1991-08-02
ES542013A0 (es) 1986-06-16
SU1487814A3 (ru) 1989-06-15
PT80246A (en) 1985-05-01
DE3512225A1 (de) 1985-10-17
CA1340672C (en) 1999-07-20
SE8901225D0 (sv) 1989-04-06

Similar Documents

Publication Publication Date Title
CA1276929C (en) Cephalosporin antibacterial agents
US4839350A (en) Cephalosporin compounds and the production thereof
US5401734A (en) Cephem compounds
IE53177B1 (en) Cephalosporin derivatives,their preparation and compositions containing them
CA1152062A (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4692443A (en) 3-bicyclicpyridinium-methyl cephalosporins
GB2110688A (en) A process for preparing 3-alkoxymethylcephalosporin derivatives
US4751295A (en) Cephalosporin derivatives
IE830455L (en) Cephalosporin derivatives
AU7933198A (en) A process for the selective preparation of z-isomers of a 3-(2-substituted vinyl-)-cephalosporin
GB2173798A (en) Cephalosporanic acid derivatives
GB2178032A (en) Cephalosporanic acid derivatives
EP0329785B1 (en) Cephalosporin derivatives
US4690921A (en) Cephalosporin compounds and salts thereof
US4687769A (en) 3-(3,3,3-trifluoropropenyl) cephalosporins
CA1340609C (en) Cephalosporin derivatives
GB2034692A (en) New cephem compounds and processes for preparation thereof
US4791197A (en) Cephalosporin compounds
RU2024530C1 (ru) Соединение цефема или его фармацевтически приемлемая соль
JPS6388187A (ja) 3−アンモニオプロペニルセフエム誘導体
JPS62228084A (ja) セフアロスポリン誘導体
JPH01156984A (ja) 3−プロペニルセフェム誘導体
JPS63239277A (ja) チアゾール酢酸誘導体
JPS6127991A (ja) セフアロスポリン誘導体その製造法およびそれを有効成分とする抗菌剤
JPH0717654B2 (ja) 7−チアジアゾリルアセトアミド−3−セフエム誘導体

Legal Events

Date Code Title Description
MKEX Expiry